| Critical practical aspects in the application of liquid chromatography–mass spectrometric studies for the characterization of impurities and degradation products M Narayanam, T Handa, P Sharma, S Jhajra, PK Muthe, PK Dappili, ... Journal of pharmaceutical and biomedical analysis 87, 191-217, 2014 | 96 | 2014 |
| Metabolite identification studies on amiodarone in in vitro (rat liver microsomes, rat and human liver S9 fractions) and in vivo (rat feces, urine, plasma) matrices by using … NR Varkhede, S Jhajra, DS Ahire, S Singh Rapid Communications in Mass Spectrometry 28 (4), 311-331, 2014 | 36 | 2014 |
| Extrahepatic Drug‐Metabolizing Enzymes and Their Significance S Jhajra, N Ramesh Varkhede, D Suresh Ahire, B Vidyasagar Naik, ... Encyclopedia of Drug Metabolism and Interactions, 1-99, 2011 | 15 | 2011 |
| High-resolution mass spectrometry in metabolite identification MK Ladumor, S Tiwari, A Patil, K Bhavsar, S Jhajra, B Prasad, S Singh Comprehensive Analytical Chemistry 71, 199-229, 2016 | 13 | 2016 |
| Characterization of forced degradation products of torasemide through MS tools and explanation of unusual losses observed during mass fragmentation of drug and degradation … M Kurmi, N Patel, S Jhajra, PV Bharatam, S Singh Journal of Pharmaceutical and Biomedical Analysis 145, 209-218, 2017 | 9 | 2017 |
| Detection of glutathione conjugates of amiodarone and its reactive diquinone metabolites in rat bile using mass spectrometry tools SS Keyur R. Parmar, Shalu Jhajra Rapid Communication in Mass Spectrometry 30 (10), 1242–1248, 2016 | 8 | 2016 |
| Molecular insight into atypical instability behavior of fixed-dose combination containing amlodipine besylate and losartan potassium T Handa, S Jhajra, S Bhagat, PV Bharatam, AK Chakraborti, S Singh Journal of Pharmaceutical and Biomedical Analysis 136, 66-80, 2017 | 6 | 2017 |
| Protocols for characterization of degradation products with special emphasis on mutagenic degradation impurities S Hostyn, P Persich, S Jhajra, K Vanhoutte Methods for stability testing of pharmaceuticals, 123-141, 2018 | 4 | 2018 |
| A Model Approach for Developing Stability-Indicating Analytical Methods P Persich, M Hellings, S Jhajra, P Phalke, K Vanhoutte Methods for Stability Testing of Pharmaceuticals, 99-121, 2018 | 3 | 2018 |
| Identification of stable and reactive metabolite (s) of nelfinavir in human liver microsomes and rCYP3A4 S Jhajra, S Singh Journal of Pharmaceutical and Biomedical Analysis 118, 214-227, 2016 | 3 | 2016 |
| High-resolution MS for drug metabolite identification S Jhajra, B Prasad, J Shah, S Singh Applications of High-Resolution Mass Spectrometry in Drug Discovery and …, 2014 | 2 | 2014 |
| Influence of Changes in Physiology, Transporters, and Enzyme Expression on Disposition and Metabolism of Drugs during Pregnancy and Clinical Implications S Jhajra, S Singh, KA Holm, AS Faqi, J Sahi Encyclopedia of Drug Metabolism and Interactions, 2012 | 1 | 2012 |
| EVIDENCE OF IN VITRO AND IN VIVO INTERACTION BETWEEN alpha-HYDROXY ALDEHYDE METABOLITE OF ATAZANAVIR AND ISONIAZID S Jhajra, S Singh DRUG METABOLISM REVIEWS 47, 108-108, 2015 | | 2015 |
| Explanation through density functional theory of the unanticipated loss of CO2 and differences in mass fragmentation profiles of ritonavir and its rCYP3A4-mediated metabolites Shalu Jhajra, Tarun Handa, Sonam Bhatia, P. V Journal of Mass Spectrometry 49 (6), 452-467, 2014 | | 2014 |
Saranjit SinghNational Institute of Pharmaceutical Education and Research在 niper.ac.in 的电子邮件经过验证
